Save Job Back to Search Job Description Summary Similar JobsReporting direcrtly into the CFOAt the cutting edge of an highly promising and dynamic clinical stage biotechAbout Our ClientOur client is a global clinical stage biotechnology company focused on the development of innovative therapies addressing areas of high unmet medical need. With multiple near term clinical and regulatory milestones and a transition toward commercialization underway, the company is entering a critical phase of growth requiring enhanced engagement with the global investment community.Job DescriptionReporting directly to the Chief Financial Officer, the Director of Investor Relations will hold a highly visible and execution focused role during a pivotal period in the company evolution. This individual will be responsible for shaping and delivering a clear and differentiated investment narrative by translating complex scientific, clinical, and regulatory data into compelling messaging for institutional investors and sell side analysts. The role will act as a close partner to the CEO and CFO and will lead the full execution of the investor relations strategy. Main duties and responsibilities will include the following:Partner with the CEO and CFO to define and implement the investor relations strategyServe as a primary point of contact for institutional investors, sell side analysts, and shareholdersOwn and continuously refine the investment thesis and equity storyLead day to day IR execution including earnings preparation, investor presentations, Q&A preparation, conferences, roadshows, and investor targetingTranslate preclinical and clinical data, mechanisms of action, trial endpoints, statistical outcomes, safety profiles, and competitive positioning into clear investor focused messagingSupport investor communications surrounding clinical readouts and regulatory milestones including submissions, advisory committees, and approvalsDraft and coordinate scientific and financial content for investor decks, press releases, scripts, and IR website materials in alignment with finance, legal, and communications teamsBuild and maintain long term relationships with leading biotechnology investors and analystsMonitor peer companies, competitive landscape, clinical developments, regulatory changes, and sector trendsTrack analyst models, consensus expectations, and key valuation drivers, providing actionable insights to senior leadershipEnsure all external communications comply with SEC and disclosure requirements including support for earnings releases and public filingsMaintain ownership of IR infrastructure including website content, investor calendars, shareholder surveillance, and engagement analyticsSupport development of commercialization and launch related messaging in collaboration with commercial leadershipIntegrate scientific, clinical, financial, and commercial narratives into a cohesive and credible equity storyThis is a pivotal role which requires regular travel to Europe, +/- 50% of the time. When not traveling, part of the role can be HYBRID and there is an office close to Waltham, MA.Page Executive is the global executive search, senior leadership recruitment, and executive advisory arm of PageGroup plc. PageGroup PLC was established in the United Kingdom in 1976. With over 45 years of experience, PageGroup is a globally recognized leader in professional recruitment. Operating across 36 markets with more than 130 offices, our expertise spans multiple industries and job functions. We provide tailored recruitment solutions through four distinct brands. The Successful ApplicantIn return for a competitive remuneration package, the successful candidate will possess the following:Bachelor's degreeAdvanced degree in some sort of Scientific field e.g. PhD, MD, or PharmD etc.MBA or equivalent finance training strongly preferred, CFA a plus7+ or more years of relevant experience in investor relations, equity research, investment banking, or consulting within biotechnology or pharmaceuticalsStrong understanding of clinical trial design, biostatistics, and FDA and EMA regulatory pathwaysPrior experience supporting public company disclosure and earnings cyclesProven ability to communicate complex scientific and clinical data to sophisticated investor audiencesStrong understanding of biotechnology valuation driversExecutive presence with confidence engaging senior leadership and external stakeholdersHigh attention to detail with strong cross functional collaboration skillsWhat's on Offer$ 280,000 to $ 300,000 base salaryPerformance related annual bonus schemeA highly visible leadership role within a rapidly evolving clinical stage biotech companyDirect exposure to C suite leadership and board level stakeholdersOpportunity to shape the market narrative through key clinical and commercial milestonesContactTom SmithQuote job refJN-042026-7005496Job summarySectorLife SciencesSub SectorBiotechnologyIndustryHealthcare / PharmaceuticalLocationWalthamContract TypePermanentConsultant nameTom SmithJob ReferenceJN-042026-7005496Job NatureHybrid working
